Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALPS”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableUnknownNCT04309266
What this trial is testing

The Impact of Robot Assisted Therapy and Metacognitive Skills Training for Children With Hemiparesis

Who this might be right for
HemiparesisHemiplegic Cerebral PalsyHemiparesis;Poststroke/CVA
Boston Children's Hospital 2
Not applicableUnknownNCT05245136
What this trial is testing

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Who this might be right for
Characteristics DiseaseMetastatic CancerSolid Tumor
University Hospital Augsburg 3,000
Not applicableStudy completedNCT00068146
What this trial is testing

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

Who this might be right for
Lymphoproliferative DisordersLymphoma
National Institute of Allergy and Infectious Diseases (NIAID) 77
Not applicableLooking for participantsNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 500
Early research (Phase 1)Study completedNCT00065390
What this trial is testing

Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome

Who this might be right for
Autoimmune DiseaseLymphatic DiseaseLymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 8
Large-scale testing (Phase 3)Study completedNCT01222247
What this trial is testing

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

Who this might be right for
PregnancyRespiratory Distress SyndromePregnancy Outcomes+1 more
The George Washington University Biostatistics Center 2,831
Post-approval studies (Phase 4)Study completedNCT00893425
What this trial is testing

Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

Who this might be right for
ProteinuriaDiabetic NephropathyChronic Kidney Disease
Gulhane School of Medicine 78
Not applicableUnknownNCT06076330
What this trial is testing

Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 120
Not applicableLooking for participantsNCT00001350
What this trial is testing

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
Benign Lymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Not applicableLooking for participantsNCT03328650
What this trial is testing

Clinical Outcomes of the ALPS Proximal Humerus Plating System

Who this might be right for
Proximal Humeral Fracture
Vanderbilt University Medical Center 150
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)UnknownNCT02828878
What this trial is testing

Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
Cellect Biotechnology 12
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Not applicableStudy completedNCT06693947
What this trial is testing

Impact of Alpine Dairy Products on Blood Lipid Levels

Who this might be right for
Elevated Cholesterol
University of Fribourg 29
Not applicableLooking for participantsNCT06781437
What this trial is testing

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Who this might be right for
Lymphoproliferative Syndrome, AutoimmuneLymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 5,500
Not applicableWithdrawnNCT01672918
What this trial is testing

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

Who this might be right for
Autoimmune Lymphoproliferative SyndromeLymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT04695457
What this trial is testing

Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps

Who this might be right for
Covid19Nursing Home
Centre Hospitalier Annecy Genevois 74
Testing effectiveness (Phase 2)Looking for participantsNCT06730126
What this trial is testing

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

Who this might be right for
Autoimmune Lymphoproliferative Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Study completedNCT00013689
What this trial is testing

Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

Who this might be right for
Autoimmune DiseaseLymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 8
Load More Results